vs

Side-by-side financial comparison of OP Bancorp (OPBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

OP Bancorp is the larger business by last-quarter revenue ($24.3M vs $13.2M, roughly 1.8× TriSalus Life Sciences, Inc.). On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 13.7%). OP Bancorp produced more free cash flow last quarter ($23.4M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 11.4%).

OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

OPBK vs TLSI — Head-to-Head

Bigger by revenue
OPBK
OPBK
1.8× larger
OPBK
$24.3M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+46.1% gap
TLSI
59.8%
13.7%
OPBK
More free cash flow
OPBK
OPBK
$25.9M more FCF
OPBK
$23.4M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
11.4%
OPBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPBK
OPBK
TLSI
TLSI
Revenue
$24.3M
$13.2M
Net Profit
$-9.8M
Gross Margin
86.7%
Operating Margin
39.2%
-24.8%
Net Margin
-73.9%
Revenue YoY
13.7%
59.8%
Net Profit YoY
3.5%
EPS (diluted)
$0.48
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPBK
OPBK
TLSI
TLSI
Q4 25
$24.3M
$13.2M
Q3 25
$24.5M
$11.6M
Q2 25
$23.7M
$11.2M
Q1 25
$22.2M
$9.2M
Q4 24
$21.3M
$8.3M
Q3 24
$20.7M
$7.3M
Q2 24
$20.4M
$7.4M
Q1 24
$19.6M
$6.5M
Net Profit
OPBK
OPBK
TLSI
TLSI
Q4 25
$-9.8M
Q3 25
$6.7M
$-10.8M
Q2 25
$6.3M
$-8.3M
Q1 25
$5.6M
$-10.4M
Q4 24
$-10.1M
Q3 24
$5.4M
$-2.4M
Q2 24
$5.4M
$-4.3M
Q1 24
$5.2M
$-13.2M
Gross Margin
OPBK
OPBK
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
OPBK
OPBK
TLSI
TLSI
Q4 25
39.2%
-24.8%
Q3 25
39.5%
-77.9%
Q2 25
35.7%
-65.4%
Q1 25
34.6%
-79.9%
Q4 24
31.2%
-91.8%
Q3 24
36.5%
-118.9%
Q2 24
37.2%
-111.0%
Q1 24
37.1%
-180.8%
Net Margin
OPBK
OPBK
TLSI
TLSI
Q4 25
-73.9%
Q3 25
27.4%
-93.5%
Q2 25
26.7%
-73.9%
Q1 25
25.0%
-113.2%
Q4 24
-122.4%
Q3 24
26.2%
-32.6%
Q2 24
26.7%
-58.8%
Q1 24
26.7%
-204.5%
EPS (diluted)
OPBK
OPBK
TLSI
TLSI
Q4 25
$0.48
$-0.22
Q3 25
$0.45
$-0.96
Q2 25
$0.42
$-0.27
Q1 25
$0.37
$-0.39
Q4 24
$0.33
$-0.38
Q3 24
$0.36
$-0.12
Q2 24
$0.36
$-0.21
Q1 24
$0.34
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPBK
OPBK
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$167.3M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$227.9M
$-33.9M
Total Assets
$2.7B
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPBK
OPBK
TLSI
TLSI
Q4 25
$167.3M
$20.4M
Q3 25
$166.7M
$22.7M
Q2 25
$205.4M
$26.5M
Q1 25
$198.9M
$13.0M
Q4 24
$134.9M
$8.5M
Q3 24
$166.8M
$11.3M
Q2 24
$127.7M
$16.5M
Q1 24
$139.2M
$4.0M
Stockholders' Equity
OPBK
OPBK
TLSI
TLSI
Q4 25
$227.9M
$-33.9M
Q3 25
$221.5M
$-26.7M
Q2 25
$213.7M
$-19.4M
Q1 25
$210.1M
$-34.4M
Q4 24
$205.0M
$-25.9M
Q3 24
$203.6M
$-20.4M
Q2 24
$195.9M
$-25.3M
Q1 24
$194.7M
$-36.0M
Total Assets
OPBK
OPBK
TLSI
TLSI
Q4 25
$2.7B
$35.3M
Q3 25
$2.6B
$36.5M
Q2 25
$2.6B
$41.3M
Q1 25
$2.5B
$28.6M
Q4 24
$2.4B
$24.0M
Q3 24
$2.4B
$27.5M
Q2 24
$2.3B
$32.4M
Q1 24
$2.2B
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPBK
OPBK
TLSI
TLSI
Operating Cash FlowLast quarter
$26.2M
$-2.5M
Free Cash FlowOCF − Capex
$23.4M
$-2.5M
FCF MarginFCF / Revenue
96.2%
-19.1%
Capex IntensityCapex / Revenue
11.5%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.3M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPBK
OPBK
TLSI
TLSI
Q4 25
$26.2M
$-2.5M
Q3 25
$23.9M
$-3.7M
Q2 25
$-7.0M
$-7.3M
Q1 25
$5.6M
$-4.5M
Q4 24
$31.2M
$-5.7M
Q3 24
$13.3M
$-10.8M
Q2 24
$15.8M
$-13.4M
Q1 24
$-3.2M
$-10.9M
Free Cash Flow
OPBK
OPBK
TLSI
TLSI
Q4 25
$23.4M
$-2.5M
Q3 25
$23.4M
$-3.9M
Q2 25
$-7.7M
$-7.4M
Q1 25
$4.2M
$-5.3M
Q4 24
$29.7M
$-5.8M
Q3 24
$12.8M
$-11.0M
Q2 24
$15.7M
$-13.5M
Q1 24
$-3.2M
$-10.9M
FCF Margin
OPBK
OPBK
TLSI
TLSI
Q4 25
96.2%
-19.1%
Q3 25
95.6%
-33.9%
Q2 25
-32.5%
-66.1%
Q1 25
19.0%
-57.3%
Q4 24
139.0%
-69.7%
Q3 24
61.5%
-149.9%
Q2 24
77.0%
-183.1%
Q1 24
-16.6%
-169.3%
Capex Intensity
OPBK
OPBK
TLSI
TLSI
Q4 25
11.5%
0.3%
Q3 25
2.3%
1.9%
Q2 25
3.0%
0.8%
Q1 25
6.4%
8.2%
Q4 24
7.3%
0.6%
Q3 24
2.8%
2.3%
Q2 24
0.4%
0.8%
Q1 24
0.5%
1.0%
Cash Conversion
OPBK
OPBK
TLSI
TLSI
Q4 25
Q3 25
3.57×
Q2 25
-1.10×
Q1 25
1.02×
Q4 24
Q3 24
2.45×
Q2 24
2.90×
Q1 24
-0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons